Skip to main content
. 2017 Mar 3;2017(3):CD010503. doi: 10.1002/14651858.CD010503.pub2
# Query Results
S37 S24 AND S36 41
S36 S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 1,032,949
S35 TX allocat* random* 4,840
S34 (MH "Quantitative Studies") 14,288
S33 (MH "Placebos") 9,653
S32 TX placebo* 37,534
S31 TX random* allocat* 4,840
S30 (MH "Random Assignment") 40,672
S29 TX randomi* control* trial* 101,812
S28 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 820,358
S27 TX clinic* n1 trial* 183,294
S26 PT Clinical trial 79,261
S25 (MH "Clinical Trials+") 196,591
S24 S15 AND S23 151
S23 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 16,567
S22 TX Estraderm 5
S21 TX Oestridae 1
S20 TX Oestrone 13
S19 TX vivelle 2
S18 TX oestrogen* or TX oestradiol 1,139
S17 TX estrogen* or TX estradiol 15,502
S16 (MM "Estrogens, Conjugated") OR (MM "Estrogens+") 4,943
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 2,631
S14 TX(luteal N2 symptom*) 18
S13 TX (Premenstrual N2 dysphor*) 316
S12 TX PMT 166
S11 TX(Premenstrual N2 depressi*) 27
S10 TX mastalgi* 77
S9 TX(luteal N2 dysphori*) 12
S8 TX (Dysphor* N2 disorder*) 331
S7 TX PMT 166
S6 TX Premenstrual Tension 44
S5 TX LLPDD 7
S4 TX PMD* 460
S3 TX PMS 974
S2 TX Premenstrual Syndrome 1,347
S1 (MM "Premenstrual Syndrome+") OR (MM "Premenstrual Dysphoric Disorder") 1,013
HHS Vulnerability Disclosure